Clinical Trials for TP53 Mutation

Find clinical trials for tp53 mutation. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer

NCT ID: NCT06413992

This clinical trial is studying a combination of two treatments—camrelizumab and fluzoparib—specifically for women with recurrent or advanced endometrial cancer that has a mutation in the TP53 gene...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, Beijing, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Prostate Cancer View clinical trials → Healthy View clinical trials →

Search All Trials Browse All Conditions